Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -365.40K | -513.30K | -816.90K | -601.80K | -514.70K |
| Total Depreciation and Amortization | 87.30K | 86.40K | 90.70K | 98.60K | 95.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 149.40K | 35.30K | 497.60K | 370.80K | 249.60K |
| Change in Net Operating Assets | 160.60K | 830.90K | 37.60K | -58.60K | -140.80K |
| Cash from Operations | 32.00K | 439.30K | -191.10K | -191.00K | -310.80K |
| Capital Expenditure | -- | 0.00 | -- | -- | -600.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 1.87M | -- | -- | -- |
| Cash from Investing | -- | 1.87M | -- | -- | -600.00 |
| Total Debt Issued | 15.00K | -2.48M | 360.60K | 262.00K | 112.00K |
| Total Debt Repaid | -56.00K | -387.20K | -57.20K | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -377.60K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 377.60K |
| Cash from Financing | -29.80K | -2.38M | 217.30K | 191.00K | 348.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 45.80K | -46.10K | -- |
| Net Change in Cash | 2.20K | -71.60K | 72.10K | -46.10K | 36.80K |